The Skagit Valley choir last sang together on the evening of March 10, 2020. This rehearsal, it would turn out, was one of the first documented superspreader events of the pandemic. Of the 61 choristers who attended practice that night, 53 developed coronavirus symptoms. Two later died.

The event served as an example to other choirs of the dangers of coming together in the pandemic. It also provided crucial evidence for scientists seeking to understand how the coronavirus was being transmitted.

Today, a look at the Skagit Valley case and the choir’s road to singing together once again.

This story was written and narrated by Kim Tingley. To hear more audio stories from publishers like The New York Times, download Audm for iPhone or Android.

Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.

This episode contains strong language and emotional descriptions about the challenges of parenting during the pandemic, so if your young child is with you, you might want to listen later.

Several months ago, The Times opened up a phone line to ask Americans what it’s really been like to raise children during the pandemic.

Liz Halfhill, a single mother to 11-year-old Max, detailed her unvarnished highs and lows over the past year.

Guest: Liz Halfhill, a single mother and full-time paralegal, in Spokane, Wash.

Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. 

Background reading: 

• The Times followed Liz and two other mothers in different parts of America who shared their experience of pandemic parenting over dozens of interviews. What emerged was a story of chaos and resilience, resentment and persistence, and of course, hope.
• Take a look at “The Primal Scream,” a series from The Times that examines the pandemic’s effect on working mothers in America.

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.

Federal health agencies on Tuesday called for a pause in the use of Johnson & Johnson’s coronavirus shot as they examine a rare blood-clotting disorder that emerged in six recipients.

Every state, the District of Columbia and Puerto Rico halted their rollout of the Johnson & Johnson vaccine almost immediately. The same went for the U.S. military, federally run vaccination sites, and CVS, Walgreens, and other stores.

Today, science writer Carl Zimmer explains the decision-making process, how long the suspension might last and the impact it could have not only in the U.S. but around the world.

Guest: Carl Zimmer, a science writer and author of the “Matter” column for The New York Times.

Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. 

Background reading: 

• Injections of Johnson & Johnson’s coronavirus vaccine came to a sudden halt across the United States on Tuesday after federal health agencies called for a pause in the vaccine’s use.
• The pause could continue for a week to 10 days, after expert advisers to the Centers for Disease Control and Prevention determined on Wednesday that they needed more time to assess a possible link to a rare but serious blood-clotting disorder.
• What does the pause mean for people who have recently received the Johnson & Johnson shot and how common are blood clots? Here’s what you need to know.
• Safety worries about the AstraZeneca and Johnson & Johnson vaccines have jeopardized inoculation campaigns far beyond the United States. The actions of American and European officials have stoked doubts in poorer countries, where a history of colonialism and unethical medical practices have left a legacy of mistrust in vaccines.

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.

In a ruling a few days ago, the Supreme Court lifted coronavirus restrictions imposed by California on religious services held in private homes. The decision gave religious Americans another win against government rules that they say infringe on their freedom to worship.

With the latest victory, the question has become whether the Supreme Court’s majority is protecting the rights of the faithful or giving them favorable treatment.

Guest: Adam Liptak, who covers the Supreme Court for The Times.

Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. 

Background reading: 

• Late Friday night, the Supreme Court lifted California’s restrictions on religious gatherings in private homes. The order followed earlier ones striking down limits on attendance at houses of worship.
• A study that considered data from the past 70 years found that the Supreme Court had become far more likely to rule in favor of religious rights in recent years.

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday. 

Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.

It started with a picture posted on the internet, and ended in an extravagant cryptocurrency bidding war. NFTs, or “nonfungible tokens,” have recently taken the art world by storm. Sabrina Tavernise, a national correspondent for The Times, speaks with the Times columnist Kevin Roose about digital currency’s newest frontier, his unexpected role in it and why it matters.

Guest: Kevin Roose, a technology columnist for The Times who examines the intersection of technology, business, and culture.

Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. 

Background reading: 

• NFT mania has reached new highs in recent months, with a digital artwork by an artist known as Beeple selling for $69.3 million. A trading card featuring the quarterback Tom Brady sold for $1.3 million and an NFT of the first tweet from Jack Dorsey, the chief executive of Twitter, went for $2.9 million.
• What are these nonfungible tokens and why do people pay so much for them? Here’s a primer.
• A picture of Kevin Roose’s column “Buy This Column on the Blockchain!” was put up for auction and sold for about $725,000. He also wrote about the surreal experience of selling the NFT and spoke to a few people who placed bids.

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.

Europe’s vaccination process was expected to be well-orchestrated and efficient. So far, it’s been neither. Sabrina Tavernise, a national correspondent for The Times, spoke with our colleague Matina Stevis-Gridneff about Europe’s problems and why things could get worse before they get better.

Guest: Matina Stevis-Gridneff, the Brussels correspondent for The New York Times, covering the European Union.

Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. 

Background reading: 

• A cascade of small decisions has led to increasingly long delays in the European Union’s inoculation efforts. While Washington went into business with the drug companies, Brussels took a conservative, budget-conscious approach that left the open market largely untouched. And it has paid for it.
• Falling behind the pace of vaccine rollouts in countries like Britain, the United States and Israel, Europe is now tightening export rules in a bid to speed up its inoculation campaign and stem political criticism.

For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.

The author Philip Roth, who died in 2018, was not sure whether he wanted to be the subject of a biography. In the end, he decided that he wanted to be known and understood.

His search for a biographer was long and fraught — Mr. Roth parted ways with two, courted one and sued another — before he settled on Blake Bailey, one of the great chroniclers of America’s literary lives.

Today on The Sunday Read, the journey of rendering a writer whose life was equal parts discipline and exuberance.

This story was written by Mark Oppenheimer and recorded by Audm. To hear more audio stories from publishers like The New York Times, download Audm for iPhone or Android.

Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.

Odessa is a four-part series. All episodes of the show released so far are available here. 
Last fall, as Odessa High School brought some students back to campus with hybrid instruction, school officials insisted mask wearing, social distancing and campus contact tracing would keep students and faculty safe. And at the beginning of the semester, things seemed to be going OK. But then a spike in coronavirus cases hit town, putting the school’s safety plan to the test. 

In part three of our four-part series, we follow what happened when a student quarantine stretched the school’s nurses to capacity, fractured friendships and forced some marching band members to miss a critical rite of passage: the last football game of their high school career.

Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.

In Minneapolis, the tension is palpable as the city awaits the outcome of the trial of Derek Chauvin, the police officer accused of murdering George Floyd last summer.

The court proceedings have been both emotional — the video of Mr. Floyd’s death has been played over and over — and technical.

At the heart of the case: How did Mr. Floyd die?

Today, we look at the case that has been brought against Mr. Chauvin so far. 

Guest: John Eligon, a national correspondent covering race for The New York Times. 

Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. 

Background reading: 

• Bystanders’ pain had been mostly hidden for the last 10 months. But over the first week of Derek Chauvin’s murder trial, it spilled tearfully into the open as witnesses testified to their shared trauma.
• Follow along live here for the latest updates on the trial of Mr. Chauvin.
• What to know about the death of George Floyd.

For more information on today’s episode, visit 

nytimes.com/thedaily

. Transcripts of each episode will be made available by the next workday.

Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.

The I.R.S. says that Bristol Myers Squibb, America’s second-largest drug company, has engaged a tax-shelter setup that has deprived the United States of $1.4 billion in tax revenue.

The Biden administration is looking to put an end to such practices to pay for its policy ambitions, including infrastructure like improving roads and bridges and revitalizing cities.

We look at the structure of these tax arrangements and explore how, and whether, it’s possible to clamp down on them. 

Guest: Jesse Drucker, an investigative reporter on the Business desk for The New York Times.

Sign up here to get The Daily in your inbox each morning. And for an exclusive look at how the biggest stories on our show come together, subscribe to our newsletter. 

Background reading: 

• The I.R.S. says that Bristol Myers Squibb used an “abusive” offshore setup to avoid $1.4 billion in federal taxes.
• In a speech to the Chicago Council on Global Affairs, Treasury Secretary Janet Yellen made the case for a global minimum corporate tax rate, kicking off the Biden administration’s effort to help raise revenue in the United States. 

For more information on today’s episode, visit 

nytimes.com/thedaily

. Transcripts of each episode will be made available by the next workday.

Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.